Management of progressive multifocal leukoencephalopathy associated with natalizumab--possibilities and responsibility.
Holmøy
T
T
Hestvik
A L K
AL
Vartdal
F
F
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D039441:Integrin alpha4 / Q000276:immunology*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000209:etiology*; D000069442:Natalizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab; D039441:Integrin alpha4